Cardiovascular risk in 26,008 European overweight children as established by a multicenter database

Dagmar I'Allemand1, Susanna Wiegand, Thomas Reinehr

  • 1Children's Hospital of Eastern Switzerland, St Gallen, Switzerland. dagmar.lallemand@kispisg.ch

Insights

Overweight and obese European children frequently have cardiovascular disease risk factors, which increase with weight severity. Comprehensive screening is recommended for all overweight or obese children due to these prevalent comorbidities.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Risk Assessment
  • Public Health Nutrition

Background:

  • The rising prevalence of childhood obesity in Europe necessitates understanding associated health risks.
  • Lack of consensus exists regarding population-specific comorbidity prevalence and diagnostic strategies for pediatric obesity.

Purpose of the Study:

  • To assess weight-related risk factors, their interrelationships, and associations with biological parameters in a large cohort of overweight (OW) European children.
  • To evaluate the feasibility of electronic patient documentation in a large-scale obesity care network.

Main Methods:

  • Evaluation of data from 26,008 children (age 12.6±2.9 years) with overweight (BMI >90th percentile) or obesity (>97th percentile) across 98 specialized centers.
  • Standardized longitudinal documentation using Adipositas Patienten Verlaufsbeobachtung (APV) software, followed by central analysis including multiple logistic regression.

Main Results:

  • 41% of children were obese (OB) and 37% extremely obese (XXL).
  • 50% had at least one risk factor, and 11% had a cluster of two, including elevated blood pressure (35.4%) and dyslipidemia (32%).
  • Higher degrees of overweight were directly associated with clustered risk factors, impaired glucose metabolism, elevated blood pressure, and triglycerides, but not LDL-cholesterol.

Conclusions:

  • Cardiovascular disease risk factors are common in young Europeans with overweight or obesity and tend to cluster.
  • The degree of overweight is significantly associated with the presence and clustering of these risk factors.
  • Comprehensive screening for comorbidities is strongly justified in all overweight or obese children, and electronic documentation systems are effective in large networks.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...